Nicaragua participará en los ensayos de la vacuna rusa contra el cáncer: esto es lo que se sabe
Nicaragua participará en los ensayos en humanos de la vacuna rusa contra el cáncer “EnteroMix”. Aún no está claro si el país aportará pacientes, médicos o si el fármaco llegará a territorio nacional.
TL;DR
- Nicaragua will participate in human trials for the Russian cancer vaccine "EnteroMix".
- The vaccine is an immunotherapy designed to train the immune system to target cancer cells.
- Preclinical trials in animals showed positive results in reducing tumor growth.
- Human trials are expected to start within the next six weeks, with Nicaragua being part of the process.
- It is unclear if Nicaragua will provide patients, medical staff, or if the drug will be administered in the country.
- The vaccine is reportedly aimed at colorectal cancer, melanoma, and glioblastoma, with potential for other aggressive tumors.
- The World Health Organization has not yet evaluated or approved the vaccine, emphasizing the need for rigorous clinical trial phases.